Latest pulmonary disease News

Nicotine pouches, vaping or cigarettes: Which nicotine product is actually the least harmful?
Reducing wait times through expanded Pulmonary rehabilitation services
HKUST Develops Breakthrough Liquid-Metal Smart Patch for Clinical-Grade At-Home Cardiorespiratory Monitoring
How the pro-nicotine ‘wellness’ movement rebranded an addictive drug
Patient safety at the heart of forthcoming WHO asthma guidelines
First biologic treatment on the PBS for uncontrolled chronic obstructive pulmonary disease (COPD)
NSW pharmacists to treat more conditions: ear infections, wound care & chronic illness
Tozorakimab demonstrated statistically significant and highly clinically meaningful reduction in COPD exacerbations in OBERON and TITANIA Phase III trials
Tezspire demonstrates positive Phase III results in eosinophilic esophagitis across both co-primary and all key secondary endpoints
Cancer Council Warns Tradies Of Hidden Cancer Risks On Job
New Pneumococcal Vaccine For Adults On NIP
Revolutionising Treatment Of Lung Disease
Newly listed vaccine in expanded adult pneumococcal National Immunisation Program
New SDG data shows stalled progress on air pollution and health
Blood signature found to predict lung cancer risk years before diagnosis
Almost one in 10 people in high-risk groups may have had a hidden heart attack, study suggests
Faster Healthcare, Stronger Lifestyle For Territorians
Strengthening asthma and COPD care through primary health care in Nepal and Sri Lanka
More than 140,000 Americans die from COPD each year – here’s why survival depends on more than avoiding smoking
Breztri approved in the US for asthma as first and only triple therapy for patients 12 years of age and older
WHO calls for action: “Together for health. Stand with science.” to mark World Health Day
HKUST Innovations Shine at the International Exhibition of Inventions Geneva
Why Feeling Alone May Matter More Than Being Alone
Tozorakimab met primary endpoint in both OBERON and TITANIA Phase III trials in patients with COPD
Emerging respiratory research and investigators at TSANZSRS 2026
What Is ‘air Hunger’? And Can It Be Treated?
TGA Product Information Safety Updates 23 March
Extreme heat may keep millions from exercising, linked to 500,000 early deaths yearly
What’s ‘dirty fuel’ doing to our lungs? The same as it did for most of 2025
That cosy candle? It’s also polluting the air you’re breathing
Improving Lives Of Australians With Chronic Conditions
Truck emissions cost taxpayers $6.2 billion in healthcare each year
Positive and clinically meaningful results from the Phase III KALOS and LOGOS trials for Breztri in patients with uncontrolled asthma published in…
Stopping COPD inhalers can lead to higher risk of flare-ups for 3 months
Unlocking new pathways to help Australians with severe breathing illness
What air pollution does to the human body
How to protect yourself from bushfire smoke
CCE Writes Prescription For Health In North Country
KI-CAMS Joint Symposium 2025
Submissions Open For Indoor Air Quality Inquiry
Preventable hospitalisations cost us $7.7b a year and diminish our quality of life: public health peak
Short of Breath? See Your Community Pharmacist This World COPD Day
Air Pollution Can Have Harmful Effects On Your Lung Health
Monash spinout RAGE Biotech secures $29 million to advance next-generation RNA therapeutics
Report calls for action on deadly lung disease affecting half-a-million Australians
Cornell startup aims to monitor heart and lung health without touch
Singing Programs Can Help Those With Lung Disease
Trial Begins For Inhaler To Treat COPD Conditions